Send this to a friend

Boston Scientific settles global patent spat with Edwards Lifesciences after $180M payment

Major biotech player Boston Scientific and its California competitor Edwards Lifesciences are resolving a global patent spat in all courts around the world.
All pending cases or appeals in courts and patent offices will be dismissed with a one-time $180 million payment from Edwards to Marlborough-headquartered Boston Scientific.
No further royalties will be owed by either company and any injunctions currently in ...

Fields marked in red are required
Your name
Your email
Recipient addresses
(Separate multiple addresses with commas)

Personal message

Copyright 2017 New England Business Media